Rebastinib (DCC-2036)
Product Specifications
CAS Number
1020172-07-9
Target
Bcr-Abl
Applications
Protein Tyrosine Kinase
Smiles
CC (C) (C) C1=NN (C (=C1) NC (=O) NC2=C (C=C (C=C2) OC3=CC (=NC=C3) C (=O) NC) F) C4=CC5=C (C=C4) N=CC=C5
Molecular Formula
C30H28FN7O3
Additionnal Information
Rebastinib (DCC-2036) is a conformational control Bcr-Abl inhibitor for Abl1 (WT) and Abl1 (T315I) with IC50 of 0.8 nM and 4 nM, also inhibits SRC, LYN, FGR, HCK, KDR, FLT3, and Tie-2, and low activity to seen towards c-Kit. Phase 1.
Storage Conditions
2 years -80 in solvent
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNUM2046-50 1x 50 µL
ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), 1mg/mL
Sign In for Pricing
View Details 
BNC880891-100 1x 100 µL
Mucin 6 (MUC6) (CLH5), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details ![PE Anti-Mouse CD45.2 Antibody[104.2]](https://cdn.genprice.uk/products/763/68dd14a3061270361e7d10e1/imageurl/e-ab-f1122d.webp)